## VTR: Ventas, Inc. - XLRE: Real Estate

### Executive Summary

No thesis match: MRS_10 0.9% below STRENGTH zone (3.0-6.0%); PEG 1.74 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($75.91)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 9
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. Hudson Bay Capital Management LP Makes New Investment in Ventas, Inc. $VTR**
- Source: MarketBeat | 20251215T105904 | Somewhat-Bullish | Relevance: 100%
- Hudson Bay Capital Management LP has made a new investment in Ventas, Inc. ($VTR), purchasing 278,193 shares valued at approximately $17.57 million. This investment comes as Ventas demonstrates strong financials, beating EPS estimates and showing significant revenue growth. Despite a high payout ratio for its dividend, the company maintains a "Moderate Buy" consensus analyst rating.

**2. Engineers Gate Manager LP Buys 1,031,535 Shares of Ventas, Inc. $VTR**
- Source: MarketBeat | 20251213T105021 | Bullish | Relevance: 100%
- Engineers Gate Manager LP significantly increased its holdings in Ventas, Inc. ($VTR) by 863.6% in Q2, purchasing 1,031,535 shares to bring their total to 1,150,977 shares, now valued at approximately $72.68 million and making Ventas its second-largest position. Ventas has reported strong quarterly earnings, beating estimates with EPS of $0.88 and revenue of $1.49 billion, and institutional ownership stands at a high 94.18%. The company also announced a quarterly dividend of $0.48 per share, representing a 2.5% yield.

**3. Ventas (VTR) Valuation Check After Strong Q3 and Accelerated Senior Housing Expansion**
- Source: Simply Wall Street | 20251215T172952 | Somewhat-Bullish | Relevance: 98%
- Ventas (VTR) recently affirmed a quarterly dividend of $0.48 per share, following a strong third quarter and impressive stock performance. The company's valuation narrative suggests it is 8.1% undervalued with a fair value of $84.70, despite market ratios flashing a caution sign with a higher price-to-sales ratio compared to peers. Ventas' strategy involves active portfolio management and strategic acquisitions to drive revenue and FFO per share growth.

**4. Ventas (VTR) Valuation Check After Strong Q3 and Accelerated Senior Housing Expansion**
- Source: Simply Wall Street | 20251215T170843 | Somewhat-Bullish | Relevance: 98%
- Ventas (VTR) recently affirmed a quarterly dividend of $0.48 per share, continuing its strong income story alongside impressive stock performance. The company's valuation is being assessed after its robust third quarter, with one narrative suggesting it's 8.1% undervalued compared to its fair value of $84.70, driven by active portfolio management and strategic acquisitions. However, market ratios flash a caution sign, as its price-to-sales ratio is higher than the broader North American Health Care REITs group.

**5. Did CareTrust REITâ€™s (CTRE) First SHOP Senior Housing Acquisition Just Shift Its Investment Narrative?**
- Source: Simply Wall Street | 20251213T140924 | Neutral | Relevance: 65%
- CareTrust REIT (CTRE) recently acquired three Texas senior living communities for $40 million, marking its first investment in a Senior Housing Operating Portfolio (SHOP) and funded with cash. This move introduces a new earnings stream but also increases operational and integration risks alongside existing rapid portfolio expansion concerns. The acquisition, operated by Sinceri Senior Living, supports CareTrust's growth and diversification strategy but prompts investors to weigh the amplified upside and complexity of entering new markets and operating models.

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 2, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-04 | Keybanc | $85 | $70 | +21% |
| 2025-11-25 | Wells Fargo | $88 | $80 | +10% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-04 | Keybanc | main | Overweight |
| 2025-11-25 | Wells Fargo | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 17 ($4.24M) |
| Sells | 13 ($23.19M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 62.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 2 |

**Top Holders:**
- Vanguard Group Inc: 15.7% (+2.5%)
- JPMORGAN CHASE & CO: 12.7% (+102.6%)
- Blackrock Inc.: 11.1% (+2.6%)
- State Street Corpora: 6.2% (+3.3%)
- FMR, LLC: 5.7% (+12.1%)

### Key Risks

1. Heavy insider selling: $23M sold (13 transactions in 90 days).
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- M&A activity or partnership announcements may unlock value.
- Momentum building: MRS_10 improving +2.0% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 1.74 elevated, pricing in significant growth expectations. Analyst sentiment positive (2 raises, avg +16%). Insider selling cluster ($23.2M in 90 days), potential headwind. Institutional flow bullish (7 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $37.0B |
| Beta | 0.79 |
| 52W Range | $56.68 - $81.89 |
| Short Interest | 3.6% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.74 |
| Forward P/E | 139.3 |
| Current P/E | 291.5 |
| YoY Growth | 109.3% |
| EPS Direction | FALLING |

### Technicals

MRS_10 strengthening from -1.1% to 0.9% (+2.0% in 5 days), confirming momentum buildup. Below STRENGTH zone by 2.1pp (needs >3.0% for momentum thesis). MRS_5 at 2.0% confirms short-term momentum alignment. Long-term uptrend intact (above SMA200 at 1.15x) but short-term weakness (below SMA20). MACD histogram bearish (-0.57), momentum weakening. RSI neutral at 54. OFD pattern: +SUN (Resistance test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 0.88% (CS: 34) | Neutral |
| RSI_14 | 54.3 | Neutral |
| MACD Histogram | -0.57 | Bearish |
| vs SMA20 | 0.989x | Below |
| vs SMA50 | 1.050x | Above |
| vs SMA200 | 1.146x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $78.71
- **Stop Loss:** $75.91 (3.6% risk)
- **Target:** $81.51 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 357
- **Position Value:** $28,099.47
- **Portfolio %:** 28.10%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate risk appetite and mixed signals. VIX at moderate levels (16.5) with elevated put/call ratio suggesting cautious positioning, while normal yield curve and stable breadth indicate no systemic stress. Focus on selective opportunities with defensive positioning.*

### Earnings

**Next:** 2026-02-11 (Est: $0.09)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.05 | $0.12 | +141.9% |
| 2025Q2 | $0.14 | $0.15 | +10.4% |
| 2025Q1 | $0.07 | $0.10 | +35.8% |
| 2024Q4 | $0.05 | $0.13 | +156.6% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_10*